L forms in patients with cystic fibrosis.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000382:microbiology*; D005260:Female; D006801:Humans; D007223:Infant; D007740:L Forms / Q000302:isolation & purification*; D008171:Lung Diseases / Q000382:microbiology; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D010403:Penicillin Resistance; D011511:Proteus / Q000472:pathogenicity; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification* / Q000472:pathogenicity; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000175:diagnosis; D013210:Staphylococcus / Q000302:isolation & purification* / Q000472:pathogenicity
D000900:Anti-Bacterial Agents; D008712:Methicillin